|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$4,069
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,497,944
|
$724,898
|
Custer, Mary
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,201,344
|
$630,202
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$2,317,028
|
$463,406
|
Edelman, Daniel
|
CCR (NCI)
|
|
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
|
ZIB BC 010906
|
$1,947,268
|
$778,907
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,788,723
|
$1,430,978
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,562,883
|
$156,288
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Experimental Pathology Laboratory (EPL)
|
ZIC BC 011638
|
$1,402,891
|
$140,289
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,344,149
|
$67,207
|
Chinquee, Joseph
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$76,612
|
Barr, Frederic
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,022,127
|
$766,596
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
|
ZIA BC 011043
|
$1,022,127
|
$1,011,906
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Consequences of chronic Interferon-gamma expression on the host
|
ZIA BC 009283
|
$1,020,013
|
$102,001
|
Young, Howard
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$1,007,541
|
$50,377
|
Gottesman, Michael
|
CCR (NCI)
|
|
Regulation of Ciliogenesis and Ciliary-related signaling
|
ZIA BC 011398
|
$997,455
|
$698,218
|
Westlake, Christopher
|
CCR (NCI)
|
|
ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping
|
1R44CA210820-01A1
|
$989,401
|
$989,401
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$924,476
|
$92,448
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
ZIA BC 010738
|
$905,521
|
$362,209
|
Hou, Steven
|
CCR (NCI)
|
|
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
|
ZIA BC 011488
|
$897,044
|
$179,409
|
Meier, Jordan
|
CCR (NCI)
|
|
CCR Genomics Core
|
ZIC BC 011623
|
$850,744
|
$85,074
|
Conner, Elizabeth
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$766,596
|
$498,287
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
$37,792
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Growth-Differentiation Factors in Organogenesis
|
ZIA BC 005093
|
$748,932
|
$674,039
|
Perantoni, Alan
|
CCR (NCI)
|
|
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
|
ZIA BC 011337
|
$677,728
|
$203,318
|
Yang, James
|
CCR (NCI)
|
|
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
|
ZIA SC 010074
|
$655,873
|
$262,349
|
Neckers, Leonard
|
CCR (NCI)
|
|
Tissue Processing-Sequencing Facility
|
ZIC BC 011044
|
$651,382
|
$390,829
|
Vocke, Cathy
|
CCR (NCI)
|
|
Signal Transduction Events and the Regulation of Cell Growth
|
ZIC SC 006743
|
$609,397
|
$91,409
|
Trepel, Jane
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$587,732
|
$35,264
|
Gottesman, Michael
|
CCR (NCI)
|
|
Targeting the MET pathway in urothelial carcinoma
|
ZIA BC 011594
|
$536,543
|
$536,543
|
Apolo, Andrea
|
CCR (NCI)
|
|
Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC
|
ZIA BC 011648
|
$532,928
|
$532,928
|
Srinivasan, Ramaprasad
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$511,155
|
$25,558
|
Khan, Javed
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$511,064
|
$383,298
|
Linehan, W. Marston
|
CCR (NCI)
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$498,365
|
$49,836
|
Garfield, Susan
|
CCR (NCI)
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$492,058
|
$49,206
|
Figg, William
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$474,811
|
$9,496
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Targeting mechanisms of radiation resistance
|
ZIA BC 011552
|
$471,373
|
$235,687
|
Citrin, Deborah
|
CCR (NCI)
|
|
Screening to identify protectors and mitigators of Radiation GI Syndrome
|
ZIA BC 011762
|
$471,373
|
$188,549
|
Citrin, Deborah
|
CCR (NCI)
|
|
Genetics of Complex Diseases and Health Disparities
|
ZIA BC 010022
|
$469,536
|
$469,536
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
|
ZID BC 011792
|
$418,466
|
$41,847
|
Pack, Svetlana
|
CCR (NCI)
|
|
The Role of Fgf Signaling in Vertebrate Development
|
ZIA BC 010338
|
$384,245
|
$76,849
|
Lewandoski, Mark
|
CCR (NCI)
|
|
Molecular biology of human polyomaviruses
|
ZIA BC 011090
|
$362,249
|
$181,125
|
Buck, Christopher
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$362,249
|
$253,575
|
Buck, Christopher
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$357,695
|
$357,695
|
Apolo, Andrea
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$356,352
|
$178,176
|
Bottaro, Donald
|
CCR (NCI)
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$339,315
|
$339,315
|
Barchi, Joseph
|
CCR (NCI)
|
|
Role of FH loss in development of HLRCC heriditary kidney cancer
|
ZIA BC 010683
|
$327,936
|
$327,936
|
Neckers, Leonard
|
CCR (NCI)
|
|
Promoting tumor cell apoptosis by death ligands
|
ZIA BC 011056
|
$327,540
|
$98,262
|
Sayers, Thomas
|
CCR (NCI)
|
|
Clinical Fellowship Training Program
|
ZIE BC 011023
|
$318,550
|
$159,275
|
Pinto, Peter
|
CCR (NCI)
|
|
Identification of Genetic Factors Associated with Infectious Diseases
|
ZIA BC 010297
|
$313,024
|
$125,210
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$312,747
|
$93,824
|
Beutler, John
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $17,681,275
|